Genenta Science S.p.A. (GNTA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.67, +1.36% vs the prior close of $0.66.
- Volume 16.20K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GNTA rises 1.4% to $0.67. Closed at $0.67, +1.36% vs the prior close of $0.66. Day range $0.66–$0.71, opened at $0.71.
GNTA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — GNTA rises 1.4% to $0.67
- Closed at $0.67, +1.36% vs the prior close of $0.66. Day range $0.66–$0.71, opened at $0.71.
- Volume was 16.20K shares, 0.3x its 50-day average of 52.88K — lighter than usual.
- Price is -28.2% vs its 50-day average ($0.93) and -38.1% vs its 200-day average ($1.08).
- 52-week range $0.55–$10.00; today's close sits at 1% of that range, 93.3% below the 52-week high.
Oct 14, 2026 — GNTA slides 8.6% to $0.66, 3 down days in a row
- Closed at $0.66, -8.59% vs the prior close of $0.72. Day range $0.66–$0.75, opened at $0.70.
- Volume was 88.30K shares, 1.7x its 50-day average of 53.28K.
- Price is -30.1% vs its 50-day average ($0.94) and -39.2% vs its 200-day average ($1.09).
- 52-week range $0.55–$10.00; today's close sits at 1% of that range, 93.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — GNTA slides 5.0% to $0.72
- Closed at $0.72, -5.00% vs the prior close of $0.76. Day range $0.72–$0.75, opened at $0.75.
- Volume was 34.20K shares, 0.6x its 50-day average of 53.32K.
- Price is -24.6% vs its 50-day average ($0.96) and -33.7% vs its 200-day average ($1.09).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.8% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — GNTA slides 3.2% to $0.76
- Closed at $0.76, -3.18% vs the prior close of $0.79. Day range $0.74–$0.76, opened at $0.75.
- Volume was 26.50K shares, 0.5x its 50-day average of 53.63K — lighter than usual.
- Price is -21.7% vs its 50-day average ($0.97) and -30.5% vs its 200-day average ($1.09).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.4% below the 52-week high.
Oct 9, 2026 — GNTA jumps 10.6% to $0.79
- Closed at $0.79, +10.56% vs the prior close of $0.71. Day range $0.73–$0.80, opened at $0.73.
- Volume was 63.00K shares, 1.2x its 50-day average of 54.18K.
- Price is -20.3% vs its 50-day average ($0.99) and -28.4% vs its 200-day average ($1.10).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.1% below the 52-week high.
Oct 8, 2026 — GNTA slides 6.0% to $0.71
- Closed at $0.71, -5.96% vs the prior close of $0.75. Day range $0.71–$0.78, opened at $0.75.
- Volume was 53.60K shares, 1.0x its 50-day average of 55.07K.
- Price is -29.0% vs its 50-day average ($1.00) and -35.5% vs its 200-day average ($1.10).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.9% below the 52-week high.
Oct 7, 2026 — GNTA slides 3.3% to $0.75
- Closed at $0.75, -3.33% vs the prior close of $0.78. Day range $0.75–$0.80, opened at $0.78.
- Volume was 23.40K shares, 0.4x its 50-day average of 56.60K — lighter than usual.
- Price is -25.4% vs its 50-day average ($1.01) and -31.6% vs its 200-day average ($1.10).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 6, 2026 — GNTA jumps 7.0% to $0.78
- Closed at $0.78, +6.99% vs the prior close of $0.73. Day range $0.74–$0.80, opened at $0.79.
- Volume was 33.80K shares, 0.6x its 50-day average of 56.67K — lighter than usual.
- Price is -24.0% vs its 50-day average ($1.03) and -29.5% vs its 200-day average ($1.11).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.2% below the 52-week high.
Oct 5, 2026 — GNTA dips 2.0% to $0.73
- Closed at $0.73, -2.01% vs the prior close of $0.75. Day range $0.71–$0.76, opened at $0.75.
- Volume was 40.00K shares, 0.7x its 50-day average of 56.84K.
- Price is -30.1% vs its 50-day average ($1.04) and -34.3% vs its 200-day average ($1.11).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.7% below the 52-week high.
Oct 2, 2026 — GNTA slides 7.3% to $0.75
- Closed at $0.75, -7.34% vs the prior close of $0.80. Day range $0.72–$0.82, opened at $0.82.
- Volume was 59.50K shares, 1.0x its 50-day average of 57.91K.
- Price is -29.8% vs its 50-day average ($1.06) and -33.1% vs its 200-day average ($1.11).
- 52-week range $0.55–$10.00; today's close sits at 2% of that range, 92.5% below the 52-week high.
GNTA latest news & SEC filings
Every SEC filing by or about GNTA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 26, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade GNTA
- How much it moves: over the last 20 sessions the average daily move was 5.03% (largest 14.9%). That is a volatile stock.
- Liquidity: about 60.69K shares (≈$40.60K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.67 vs a range of $0.55–$10.00 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 13, 2026; 6-K Oct 7, 2026; 6-K Sep 11, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
GNTA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.71 | 0.71 | 0.66 | 0.67 | 16.20K |
| Oct 14, 2026 | 0.70 | 0.75 | 0.66 | 0.66 | 88.30K |
| Oct 13, 2026 | 0.75 | 0.75 | 0.72 | 0.72 | 34.20K |
| Oct 12, 2026 | 0.75 | 0.76 | 0.74 | 0.76 | 26.50K |
| Oct 9, 2026 | 0.73 | 0.80 | 0.73 | 0.79 | 63.00K |
| Oct 8, 2026 | 0.75 | 0.78 | 0.71 | 0.71 | 53.60K |
| Oct 7, 2026 | 0.78 | 0.80 | 0.75 | 0.75 | 23.40K |
| Oct 6, 2026 | 0.79 | 0.80 | 0.74 | 0.78 | 33.80K |
| Oct 5, 2026 | 0.75 | 0.76 | 0.71 | 0.73 | 40.00K |
| Oct 2, 2026 | 0.82 | 0.82 | 0.72 | 0.75 | 59.50K |
| Oct 1, 2026 | 0.71 | 0.85 | 0.71 | 0.80 | 113.20K |
| Sep 30, 2026 | 0.70 | 0.73 | 0.70 | 0.70 | 7.60K |
| Sep 29, 2026 | 0.70 | 0.75 | 0.69 | 0.70 | 59.10K |
| Sep 28, 2026 | 0.69 | 0.73 | 0.65 | 0.69 | 51.30K |
| Sep 25, 2026 | 0.74 | 0.74 | 0.65 | 0.69 | 67.10K |
| Sep 24, 2026 | 0.69 | 0.72 | 0.65 | 0.67 | 36.90K |
| Sep 23, 2026 | 0.70 | 0.73 | 0.63 | 0.65 | 173.40K |
| Sep 22, 2026 | 0.68 | 0.73 | 0.68 | 0.70 | 97.50K |
| Sep 21, 2026 | 0.72 | 0.72 | 0.65 | 0.68 | 90.70K |
| Sep 18, 2026 | 0.72 | 0.83 | 0.65 | 0.70 | 78.50K |
About Genenta Science S.p.A.
Genenta Science S.p.A. (GNTA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in MILAN, Italy. State of incorporation: Italy. Fiscal year ends —. SEC CIK 1838716.
GNTA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Francesco Galimi | CMO& Head of Development | Apr 1, 2026 |
| Miguel Maria Mutti | Director | Apr 1, 2026 |
| Giacomoantonio Paracchi | Director | Apr 1, 2026 |
| Pierluigi Paracchi | Chief Executive Officer | May 5, 2026 |
| Paracchi Pierluigi | Chief Executive Officer | Mar 18, 2026 |
| Armon Sharei | Director | Apr 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Francesco Galimi | CMO& Head of Development | Apr 1, 2026 |
| Pierluigi Paracchi | Chief Executive Officer | May 5, 2026 |
| Paracchi Pierluigi | Chief Executive Officer | Mar 18, 2026 |
| Richard B Slansky | Chief Financial Officer | Apr 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
GNTA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
GNTA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on GNTA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.